Four new phenylethanoid glycosides (1-4), 1-β-p-hydroxyphenyl-ethyl-2-O-acetyl-3,6-di-α-L-rhamnopyranosyl-β-D-glucopyranoside (1), 1-β-p-hydroxyphenyl-ethyl-3,6-O-di-α-L-rhamnopyranosyl-β-D-glucopyranoside (2), 1-β-p-hydroxyphenyl-ethyl-2-O-acetyl-3,6-di-α-L-rhamnopyranosyl-4-p-coumaroyl-β-D-glucopyranoside (3), and 1-β-p-hydroxyphenyl-ethyl-3,6-di-α-L-rhamnopyranosyl-4-p-coumaroyl-β-D-glucopyranoside (4), together with three known compounds, were isolated from the n-butanol extract of Cistanche phelypaea aerial parts. The structural characterization of all compounds was performed by spectroscopic analyses, including 1D and 2D NMR, and HRESIMS experiments. The isolated compounds were assayed for their inhibitory activity on two enzymes involved in the peculiar glycolytic or lipidic metabolism of cancer cells, human lactate dehydrogenase (LDH) and monoacylglycerol lipase (MAGL), respectively. All the compounds showed negligible activity on LDH, whereas some of them displayed a certain inhibition activity on MAGL. In particular, compound 1 was the most active on MAGL showing an IC50 value of 88.0 µM and modeling studies rationalized the supposed binding mode of 1 in the MAGL active site.

New phenylethanoid glycosides from Cistanche phelypaea and their activity as inhibitors of monoacylglycerol lipase (MAGL)

C. Granchi;BONONI, GIULIA;A. Braca
;
M. De Leo
2018-01-01

Abstract

Four new phenylethanoid glycosides (1-4), 1-β-p-hydroxyphenyl-ethyl-2-O-acetyl-3,6-di-α-L-rhamnopyranosyl-β-D-glucopyranoside (1), 1-β-p-hydroxyphenyl-ethyl-3,6-O-di-α-L-rhamnopyranosyl-β-D-glucopyranoside (2), 1-β-p-hydroxyphenyl-ethyl-2-O-acetyl-3,6-di-α-L-rhamnopyranosyl-4-p-coumaroyl-β-D-glucopyranoside (3), and 1-β-p-hydroxyphenyl-ethyl-3,6-di-α-L-rhamnopyranosyl-4-p-coumaroyl-β-D-glucopyranoside (4), together with three known compounds, were isolated from the n-butanol extract of Cistanche phelypaea aerial parts. The structural characterization of all compounds was performed by spectroscopic analyses, including 1D and 2D NMR, and HRESIMS experiments. The isolated compounds were assayed for their inhibitory activity on two enzymes involved in the peculiar glycolytic or lipidic metabolism of cancer cells, human lactate dehydrogenase (LDH) and monoacylglycerol lipase (MAGL), respectively. All the compounds showed negligible activity on LDH, whereas some of them displayed a certain inhibition activity on MAGL. In particular, compound 1 was the most active on MAGL showing an IC50 value of 88.0 µM and modeling studies rationalized the supposed binding mode of 1 in the MAGL active site.
2018
Beladjila, K. A.; Berrehal, D.; De Tommasi, N.; Granchi, C.; Bononi, Giulia; Braca, A.; De Leo, M.
File in questo prodotto:
File Dimensione Formato  
CT.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 220.46 kB
Formato Adobe PDF
220.46 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
CT paper corr 20 dicembre.pdf

Open Access dal 11/01/2019

Tipologia: Documento in Post-print
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 247.96 kB
Formato Adobe PDF
247.96 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/889787
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 10
social impact